AKT1 and neoplasm: BMA secrete abundant IL-6[92], which induces the epithelial-mesenchymal transition in tumour cells via the JAK2/STAT3 pathway[93], and strengthens the metastatic potential of tumour cells via PI3K/AKT[94].